Aethlon Medical (AEMD) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AEMD Hot Sheet
Price: $5.75 -0.86%
Financial Fact:
Professional fees: 510.98K
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Professional fees: 510.98K
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Aethlon Medical (NASDAQ: AEMD) reported Q2 EPS of ($0.19), in-line with the analyst estimate of ($0.19).
For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
- Steris (STE) Tops Q3 EPS by 26c ; Offers Guidance
- eHealth (EHTH) Misses Q3 EPS by 45c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
